VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Colby who wrote (9840)	6/18/1998 3:46:00 PM
From: Master (Hijacked)	Read Replies (3) of 23519

The floodgates are opening. VVUS shorts hanging on by a thread... My sources say FDA Plant approval is any day... Viagra bodycount: 16... Lets get ready to RUMBLLLLLLL..... From Yahoo- VVUS got THE GOODS and shorts will be SQUEEZED next week: "Look for Upgrade by P. Webber next week. New plant / equipment cutting manufacturing cost of drug by 50%. News of the Plant approval will be released very, very, very soon. Did I say very soon. :-) I am a urologist and would like to tell some of you about the real world. MUSE is not perfect. It doesn't work well in some patients and causes pain in some patients but all in all I have a good number of satisfied patients. Viagra is also a good product but not as effective on the tougher cases. MUSE side by side with Viagra will always have it's place in the ED population. I would say that out of all ED cases (all causes) viagra will work in about 1/2 of the patients. Out of the 50% remaining, MUSE will work out well in about 1/2 of the patients. 25%(give or take 5%) of the market is a very very good market share. Now I do not know if Vivus stock price will in the near term go lower. I stepped in today and purchased 30,000 shares with a long term plan to hold Vivus for 6 months. vivus will easily be a $20.00 stock once all the smoke clears. The investment community is very upset at management since they did not tip off the analysts regarding production shortfalls last December. How would you feel if you recommended this stock to your clients and it went from the 20's to 12 in a few days? Many funds sold for a loss and then shorted Vivus just to even the score with Leeland Wilson--kind of like fliping him off. Anyway, we have a great longer term buy here at $5 7/8. I advise to buy and hold for at least 6 months for a nice gain and even 12 months for a 5+ fold gain. The stock still may go as low as $5.00/share but who knows where the bottom is! buy and hold for the long term. BTW expect FDA plant approval within a week and then a very large marketing blitz by Astra and Janssen to sell the product like Vivus wished it could. Astra had 7 billion in sales last year and is very well connected with the medical community over seas. Astra is a VERY well respected and ethical drug company and who knows may even buy this company in the near future. Anyway I better leave before those shorters crucify me for recommending Vivus. You know they want to get every penney they can befor covering. Astra just might step in soon to save all the longs - maybe even tomorrow if you are lucky! Keep your eyeballs open for press releases under symbol A."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next